Consulate Takes Aim at Readmissions with
New Diagnostics, Lab Partnership
By Maggie Flynn | July 9, 2019
The largest skilled nursing provider in Florida moved to bolster its diagnostic capabilities with an eye toward reducing costly hospital readmissions.
Consulate Health Care late last month announced a partnership agreement with TridentUSA Health Services to provide radiology, ultrasound, and laboratory services to Consulate’s senior care facilities across the U.S.
The terms of the deal were not disclosed, but the companies have been business partners for more than a decade, and the agreement formalizes a multi-year preferred provider agreement for Trident to be the primary provider of mobile diagnostic services across the portfolio of 133 Consulate facilities, Trident CEO Andrei Soran told Skilled Nursing News in an e-mail.
“Consulate currently benefits from a bundled package of diagnostic services, including X-ray, ultrasound, and clinical laboratory services,” he said. “As Consulate’s preferred provider, facilities benefit from having a single source for its most important diagnostic services.”
Trident, a mobile health solutions provider that offers diagnostics in 36 states, is also exploring additional services, such as analytics and clinical research as the acuity of patients at the Maitland, Fla.-based Consulate rises, he noted.
By enhancing Consulate’s clinical offerings, the partnership supports the SNF provider’s goal of reducing readmissions, Consulate CEO Chris Bryson said in a statement announcing the partnership.
Improving clinical offerings is top of mind for many providers as the implementation of the new Patient-Driven Payment Model (PDPM) — the overhaul of the Medicare payment system for nursing homes — draws ever closer.
The new structure, which will take effect October 1, is expected to reward SNFs that can care for more medically complex patients — and timely, accurate clinical diagnostics will help Consulate reach desired outcomes more efficiently, Soran said.
The partnership will also help Trident, he noted.
“A primary objective of this partnership is to capitalize on Trident’s investment into its technology platform, developed to deliver services that enhance the turnaround times of results to clinicians to mitigate readmissions,” Soran said. “Our analytics will assist clinicians in determining appropriate clinical pathways, better alternatives, and [provide] access to best practices.”